Clinical Trials & COVID-19

The Symmetry Study

What Is the Purpose of the Symmetry Study?

The Symmetry study is evaluating an investigational drug, efruxifermin (EFX), to find out if it can reverse liver damage in people with compensated cirrhosis due to NASH.

Who Can Join the Symmetry Study?

You may qualify for the Symmetry study if you meet the following criteria:

Other criteria will apply. Your medical history and other study requirements will be reviewed with you to determine if you may qualify.

What Will Happen During the Study?

Participation in the Symmetry study may last up to 96 weeks (about 2 years):

All study participants will have their health monitored throughout the study. Some study assessments will include blood tests and heart tests (ECG), and liver tests (liver biopsy and abdominal ultrasounds).

Does It Cost Anything to Participate?

No. All study visits, medical procedures, lab tests, supplies, and the study drug are provided at no cost. Reimbursement for study-related travel expenses may be available.